Professor Gerald Saldanha

Consultant Histopathologist / Hon Professor

School/Department: Genetics and Genome Biology, Department of

Profile

I am a clinical histopathologist specialising in dermatopathology and with a research interest in tissue biomarkers for cutaneous melanoma. My professional goal is to combine my clinical and research skills to develop a prognostic biomarker that will improve patient care worldwide for melanoma patients.

Research

I investigate tissue biomarkers for malignant melanoma a type of skin cancer

Publications

1. Toxic epidermal necrolysis-like lupus.
Roberts EJ, Melchionda V, Saldanha G, Shaffu S, Royle J, Harman KE.
Clin Exp Dermatol. 2021 Mar 24. doi: 10.1111/ced.14648. Online ahead of print.
PMID: 33760256
2. The Width of Invasion in Malignant Melanoma Is a Novel Prognostic Feature That Accounts for Outcome Better Than Breslow Thickness.
Saldanha G, Khanna A, O'Riordan M, Bamford M.
Am J Surg Pathol. 2020 Nov;44(11):1522-1527. doi: 10.1097/PAS.0000000000001529.
PMID: 32604169
3. Global and mitosis-specific interobserver variation in mitotic count scoring and implications for malignant melanoma staging.
Saldanha G, Ali R, Bakshi A, Basiouni A, Bishop R, Colloby P, Craig P, Da Forno P, Edward S, Espinosa de Los Monteros O, Evans A, Jamieson L, Rytina E, Bamford M.
Histopathology. 2020 May;76(6):803-813. doi: 10.1111/his.14052. Epub 2020 Apr 16.
PMID: 31879972
4. Development and Initial Validation of Calculated Tumor Area as a Prognostic Tool in Cutaneous Malignant Melanoma.
Saldanha G, Yarrow J, Elsheikh S, O'Riordan M, Uraiby H, Bamford M.
JAMA Dermatol. 2019 Aug 1;155(8):890-898. doi: 10.1001/jamadermatol.2019.0621.
PMID: 31241720 Free PMC article.
5. Breslow Density Is a Novel Prognostic Feature That Adds Value to Melanoma Staging.
Saldanha G, Yarrow J, Pancholi J, Flatman K, Teo KW, Elsheik S, Harrison R, O'Riordan M, Bamford M.
Am J Surg Pathol. 2018 Jun;42(6):715-725. doi: 10.1097/PAS.0000000000001034.
PMID: 29462090 Free PMC article.
6. A Novel Numerical Scoring System for Melanoma Tumor-infiltrating Lymphocytes Has Better Prognostic Value Than Standard Scoring.
Saldanha G, Flatman K, Teo KW, Bamford M.
Am J Surg Pathol. 2017 Jul;41(7):906-914. doi: 10.1097/PAS.0000000000000848.
PMID: 28368925 Free PMC article.
7. A small multimarker panel using simple immunohistochemistry methods is an adjunct to stage for cutaneous melanoma prognosis.
Romaine ST, Wells-Jordan P, de Haro T, Dave-Thakrar A, North J, Pringle JH, Saldanha G.
Melanoma Res. 2016 Dec;26(6):580-587. doi: 10.1097/CMR.0000000000000293.
PMID: 27603549
8. 5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
Saldanha G, Joshi K, Lawes K, Bamford M, Moosa F, Teo KW, Pringle JH.
Mod Pathol. 2017 Jan;30(1):60-68. doi: 10.1038/modpathol.2016.159. Epub 2016 Oct 7.
PMID: 27713424 Free PMC article.
9. Breslow density is a novel prognostic feature in cutaneous malignant melanoma.
Rashed H, Flatman K, Bamford M, Teo KW, Saldanha G.
Histopathology. 2017 Jan;70(2):264-272. doi: 10.1111/his.13060. Epub 2016 Oct 10.
PMID: 27502743 Free PMC article.
10. microRNA-10b is a prognostic biomarker for melanoma.
Saldanha G, Elshaw S, Sachs P, Alharbi H, Shah P, Jothi A, Pringle JH.
Mod Pathol. 2016 Feb;29(2):112-21. doi: 10.1038/modpathol.2015.149. Epub 2016 Jan 8.
PMID: 26743475

Supervision

Skin cancer

Teaching

Currently no commitments

Press and media

Melanoma skin cancer

Qualifications

MB ChB; PhD; MRCP(UK) FRCPath